| 分化型甲状腺癌^131I治疗对患者肝肾功能的影响 |
| |
| 引用本文： | 吴书其,李瑾,叶智轶,冯方,吴震宇,李佳宁,傅宏亮,邹仁健,王辉.分化型甲状腺癌^131I治疗对患者肝肾功能的影响[J].上海交通大学学报(医学版),2010(3):271-274. |
| |
| 作者姓名： | 吴书其 李瑾 叶智轶 冯方 吴震宇 李佳宁 傅宏亮 邹仁健 王辉 |
| |
| 作者单位： | [1]上海交通大学医学院新华医院核医学科,上海200092 [2]上海长征医院肾内科,上海200003 |
| |
| 基金项目： | 基金项目：上海市重点学科建设项目（S30203） |
| |
| 摘 要： | 目的研究应用放射性碘（^131I）治疗分化型甲状腺癌（DTC）对患者肝肾功能的影响。方法收集接受^131I治疗的106例DTC患者的临床资料，并根据^131I治疗剂量分为低剂量组（≤1．85GBq，n=19）、中剂量组（2．22GBq和2．96GBq，n=50）和高剂量组（≥3．7GBq，n=37）。对实施^131I治疗前后及各组患者的肝肾功能检查结果进行对比分析。结果接受^131I治疗前后，67例患者肝功能检查结果记录完整（低剂量组18例，中剂量组37例，高剂量组12例）。与治疗前比较，治疗后总体血清谷草转氨酶（AST）和谷丙转氨酶（ALT）水平升高（P〈0．05），但大部分（82．1％）仍在正常范围内。接受^131I治疗前后，106例患者均具有完整的肾功能检查结果记录。组内治疗前后患者血尿素氮（BUN）、肌酐（SCr）、尿酸（UA）水平比较，差异均无统计学意义（P〉0．05）。结论^131I治疗DTC对患者肝肾功能无明显影响，是较为安全的治疗方法。
|
| 关 键 词： | 放射性碘 分化型甲状腺癌 肝功能 肾功能 |
Effects of ^131I therapy for differentiated thyroid carcinoma on liver and renal function |
| |
| WU Shu-qi,LI Jin,YE Zhi-yi,FENG Fang,WU Zhen-yu,LI Jia-ning,FU Hong-liang,ZOU Ren-jian,WANG Hui.Effects of ^131I therapy for differentiated thyroid carcinoma on liver and renal function[J].Journal of Shanghai Jiaotong University:Medical Science,2010(3):271-274. |
| |
| Authors: | WU Shu-qi LI Jin YE Zhi-yi FENG Fang WU Zhen-yu LI Jia-ning FU Hong-liang ZOU Ren-jian WANG Hui |
| |
| Affiliation: | 1. Department of Nuclear Medicine, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200092, China; 2. Department of Nephrology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China) |
| |
| Abstract: | Objective To investigate the-effects of radioactive iodine （^131 I） therapy for differentiated thyroid carcinoma （DTC） on liver and renal function. Methods The clinical data of 106 patients with DTC were collected, and patients were divided into low dose group （≤1.85 GBq, n=19）, middle dose group （2.22 GBq and 2.96 GBq, n=50） and high dose group （ ≥3.7 GBq, n = 37） according to ^131I doses. The results of liver and renal examinations were compared and analysed before and after ^131I therapy among groups. Results The data of liver function were complete in 67 patients before and after ^131I therapy （low dose group, n = 18; middle dose group, n = 37; high dose group, n = 12）. Compared with those before treatment, the total aspartate aminotransferase （AST） and alanine aminotransferase （ALT） levels were higher （P 〈 0.05）, while the AST and ALT levels of the majority （82.1% ） were in the normal ranges. The data of renal function were complete in all the 106 patients before and after ^131I therapy. There was no significant difference in blood urea nitrogen （BUN）, serum creatinine （SCr） and uric acid （UA） before and after treatment in each group （P 〉0.05）. Conclusion ^131I therapy is safe for DTC, with no significant effect on liver and renal function. |
| |
| Keywords: | radioactive iodine differentiated thyroid carcinoma liver function renal function |
| 本文献已被 维普 等数据库收录！ |
|
